Netflix Inc (NASDAQ:NFLX) recently announced a 10-for-1 stock split, with trading on a split-adjusted basis set to begin next week.

Invivyd, Inc. remains a Hold rating as it advances its monoclonal antibody pipeline, notably VYD2311 as a Covid-19 vaccine alternative. VYD2311 offers broader patient coverage and intramuscular dosing, with phase 3 DECLARATION and LIBERTY trials set to begin by end of 2025; Topline data mid-2026. Company's technology shows strong variant-neutralization, and expansion into RSV and measles prevention could unlock other market opportunities.

Moody's Corporation ( MCO ) J.P. Morgan 2025 Ultimate Services Investor Conference November 18, 2025 1:20 PM EST Company Participants Robert Fauber - President, CEO & Director Conference Call Participants Andrew Steinerman - JPMorgan Chase & Co, Research Division Presentation Andrew Steinerman JPMorgan Chase & Co, Research Division Hi, everybody.

Paymentus Holdings, Inc. ( PAY ) Citi's 14th Annual FinTech Conference November 18, 2025 10:30 AM EST Company Participants Sanjay Kalra - Senior VP, CFO & Principal Accounting Officer Dushyant Sharma - Chairman, President & CEO Conference Call Participants Peter Christiansen - Citigroup Inc. Exchange Research Presentation Peter Christiansen Citigroup Inc. Exchange Research Good morning. Welcome to Citi's 14th Annual Fintech Conference.

NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff deadline. So what: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

For a stock that hit a fresh all-time high as recently as the start of November, it may come as a surprise that there's a bearish argument at all calling for a sell-off.

J.B. Hunt Transport Services, Inc. ( JBHT ) Stephens Annual Investment Conference 2025 November 18, 2025 9:00 AM EST Company Participants Brad Delco - EVP of Finance & Chief Financial Officer Bradley Hicks - President of Dedicated Contract Services & Executive VP Conference Call Participants Brady Steven Lierz - Stephens Inc., Research Division Presentation Brady Steven Lierz Stephens Inc., Research Division All right. Well, good morning, everyone.

Pegasystems Inc. ( PEGA ) Global Technology, Internet, Media & Telecommunications Conference 2025 November 18, 2025 1:20 PM EST Company Participants Kenneth Stillwell - COO & CFO Conference Call Participants Rishi Jaluria - RBC Capital Markets, Research Division Presentation Rishi Jaluria RBC Capital Markets, Research Division [Audio Gap] I cover software here at RBC. I'm delighted to have with me Ken Stillwell, who is the CFO and COO of Pega.

WestJet Airlines remains on track to take its first 737 MAX 10 jet by the end of 2026, following progress by Boeing in bringing the plane to market, as the Canadian carrier also adds new routes to South America and Europe, its CEO said on Tuesday.

New York, New York--(Newsfile Corp. - November 18, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

New York, New York--(Newsfile Corp. - November 18, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period").

I am concluding my research on the forest industry with the iShares Global Timber & Forestry ETF. The companies I have previously covered account for ~25% of WOOD's 225.6 million AUM. The Invesco MSCI Global Timber ETF is WOOD's closest competitor, with a $41.2 million AUM. Smaller size is synonymous with thinner liquidity, as reflected by a higher median bid-ask spread. Despite lower liquidity, CUT's total expense ratio of 1.02% is ~2.5x higher than WOOD's 0.40%. Considering their highly similar portfolios, it is difficult to justify such a spread.

New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Beyond Meat, Inc. (NASDAQ: BYND) for potential violations of the federal securities laws. If you invested in Beyond Meat, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/beyond-meat-inc-class-action-investigation.

New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.